Variable | Group | |||
---|---|---|---|---|
Total (N = 965) | Normal CPB (N = 557) | Prolonged CPB (N = 408) | p-value | |
Age (year, N (%)) | 0.160 | |||
< 65 | 877 (90.88) | 500 (89.77) | 377 (92.40) | |
≥65 | 88 (9.12) | 57 (10.23) | 31 (7.60) | |
Sex, N (%) | 0.300 | |||
Female | 416 (43.11) | 248 (44.52) | 168 (41.18) | |
Male | 549 (56.89) | 309 (55.48) | 240 (58.82) | |
BMI (kg/m2, N (%)) | 0.967 | |||
<23 | 425 (44.04) | 245 (43.99) | 180 (44.12) | |
≥23 | 540 (55.96) | 312 (56.01) | 228 (55.88) | |
Smoking, N (%) | 110 (11.4) | 58 (10.41) | 52 (12.75) | 0.260 |
Diabetes, N (%) | 24 (2.49) | 16 (2.87) | 8 (1.96) | 0.369 |
Hypertension, N (%) | 172 (17.82) | 100 (17.95) | 72 (17.65) | 0.902 |
Stroke, N (%) | 11 (1.14) | 5 (0.90) | 6 (1.47) | 0.602 |
Arrhythmia, N (%) | 144 (14.92) | 79 (14.18) | 65 (15.93) | 0.451 |
History of cardiovascular surgery, N (%) | 25 (2.59) | 14 (2.51) | 11 (2.70) | 0.860 |
History of VH, N (%) | 43 (4.46) | 23 (4.13) | 20 (4.90) | 0.566 |
Preop use of VA, N (%) | 120 (12.44) | 66 (11.85) | 54 (13.24) | 0.519 |
Preop use of ABX, N (%) | 82 (8.5) | 46 (8.26) | 36 (8.82) | 0.756 |
NYHA, N (%) | 0.224 | |||
I | 93 (9.64) | 54 (9.69) | 39 (9.56) | |
II | 495 (51.3) | 300 (53.86) | 195 (47.79) | |
III | 354 (36.68) | 192 (34.47) | 162 (39.71) | |
IV | 23 (2.38) | 11 (1.97) | 12 (2.94) | |
LVEF (%, M (IQR)) | 57.00 (55.00, 59.00) | 57.00 (55.00, 59.00) | 57.00 (53.00, 59.00) | 0.208 |
WBC (×109/L, M (IQR)) | 5.72 (4.78, 6.90) | 5.62 (4.75, 6.77) | 5.79 (4.80, 7.10) | 0.168 |
UA (μmol/L, M (IQR)) | 346.00 (290.00, 409.00) | 343.00 (283.00, 405.00) | 355.50 (296.00, 412.00) | 0.150 |
Creatinine (μmoI/L, M (IQR)) | 73.00 (64.00, 85.00) | 73.00 (64.00, 84.00) | 74.00 (64.22, 85.00) | 0.509 |
TC (mmol/L, M (IQR)) | 3.90 (3.27, 4.63) | 3.89 (3.31, 4.61) | 3.94 (3.25, 4.67) | 0.686 |
LDL (mmol/L, M (IQR)) | 2.52 (2.06, 3.01) | 2.50 (2.10, 3.00) | 2.55 (2.03, 3.04) | 0.929 |
GLU (mmol/L, M (IQR)) | 4.79 (4.43, 5.29) | 4.81 (4.43, 5.27) | 4.76 (4.42, 5.30) | 0.986 |
Status of the operation, N (%) | 0.051 | |||
Elective | 955 (98.96) | 555 (99.64) | 400 (98.04) | |
Urgent | 5 (0.52) | 1 (0.18) | 4 (0.98) | |
Emergency | 5 (0.52) | 1 (0.18) | 4 (0.98) | |
Aortic surgery, N (%) | 58 (6.01) | 24 (4.31) | 34 (8.33) | 0.009 |
MAZE, N (%) | 24 (2.49) | 15 (2.69) | 9 (2.21) | 0.631 |
Transfusion of blood, N (%) | 400 (41.45) | 208 (37.34) | 192 (47.06) | 0.002 |
Cross-clamp time, (min, M (IQR)) | 79 (61, 100) | 65 (54, 76) | 108 (90, 126) | <0.001 |
MHCA, N (%) | 18 (1.87) | 3 (0.54) | 15 (3.68) | <0.001 |
Type of surgery, N (%) | 0.313 | |||
Aortic valve | 538 (55.75) | 311 (55.83) | 227 (55.64) | |
Mitral valve | 143 (14.82) | 82 (14.72) | 61 (14.95) | |
Tricuspid valve | 26 (2.69) | 16 (2.87) | 10 (2.45) | |
Aortic+mitral valve | 51 (5.28) | 23 (4.13) | 28 (6.86) | |
Aortic+tricuspid valve | 5 (0.52) | 3 (0.54) | 2 (0.49) | |
Aortic+mitral+tricuspid valve | 159 (16.48) | 101 (18.13) | 58 (14.22) | |
Valve surgery+CABG | 43 (4.46) | 21 (3.77) | 22 (5.39) |